Tag: FDA Approved Cancer Drugs

Home / FDA Approved Cancer Drugs

Categories

Atezolizumab and hyaluronidase-tqjs is approved by FDA for subcutaneous injection

On September 12, 2024, the Food and Drug Administration sanctioned atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) for subcutaneous administration for all adult indications co...
fda-approved-cancer-drugs

Scan the code